Ketorolac tromethamine (Novilla Pharmaceuticals)

酮咯酸氨丁三醇 (Novilla Pharmaceuticals)

Report date: 2024/03/18 20:07:11

Base Information

Drug NameKetorolac tromethamine (Novilla Pharmaceuticals)
Drug Alias Nameketorolac tromethamine gel (Novilla Pharmaceuticals)NOV-1776
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsAcute PainArthritis, GoutyGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovilla Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAcute PainArthritis, GoutyGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A